Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 2c, Beats on Revenues

Go back to Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 2c, Beats on Revenues

Zimmer Biomet (ZBH) PT Lowered to $130 at RBC Capital

April 27, 2018 9:02 AM EDT

RBC Capital lowered its price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $140.00) while maintaining a Outperform rating.

... More

Zimmer Biomet (ZBH) PT Lowered to $146 at Needham & Company

April 27, 2018 6:28 AM EDT

Needham & Company lowered its price target on Zimmer Biomet (NYSE: ZBH) to $146.00 (from $155.00) while maintaining a Strong Buy rating.

Analyst Mike Matson commented, "ZBH's 1Q18 revenue and EPS beat consensus. Management's 2018 revenue guidance was above consensus while its EPS guidance was slightly below... More

Zimmer Biomet (ZBH) PT Lowered to $130 at Jefferies; 'Putting in the Bottom?'

April 26, 2018 1:44 PM EDT

Jefferies lowered its price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $141.00) while maintaining a Buy rating.

... More

Zimmer Biomet (ZBH) PT Lowered to $137 at BMO Capital; 'Making Very Early Progress, Resetting the Bar'

April 26, 2018 1:17 PM EDT

BMO Capital lowered its price target on Zimmer Biomet (NYSE: ZBH) to $137.00 (from $144.00) while maintaining a Outperform rating.

... More

Zimmer Biomet (ZBH) PT Raised to $117.50 at Evercore ISI

April 26, 2018 1:05 PM EDT

Evercore ISI raised its price target on Zimmer Biomet (NYSE: ZBH) to $117.50 (from $115.00) while maintaining a In Line rating.

What analsyt Vijay Kumar liked:

Management is confident on the supply recovery turnaround in July that will help accelerate sales growth... More